JUMP REPORT
SLEEP NUMBER (SNBR)
EARNINGS RELEASE - JULY 15 (AMC)
EARNINGS EXPECTATIONS:
THIS QTR: EPS: -.80/share REV: 216.3/M
___________________________________________________________
LAST QTR: EPS: .72/share ACTUAL: 1.36/share (BEAT)
____________________________________________________________
NEXT QTR: EPS: .23/share REV: 375.36/M
____________________________________________________________
FULL YR: EPS: 1.53/Share REV: 1,500/M
____________________________________________________________
BEAT/MISS RECORD: 68% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) 34.11, 7.9, 6.7
EXPECTED JUMP MOVE THIS QUARTER: 15%
——–
*** With market volatility at extremes there is greater risk in trading these events which may not react as they would under normal market conditions. Please take extra caution before trading.
Links To Latest News and Headlines
What a brutal six months it’s been for Sleep Number. The stock has dropped 67% and now trades at $1.69, rattling many shareholders. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
A number of stocks jumped in the afternoon session after a trio of major retailers reported stronger-than-expected first-quarter earnings.
Sleep Number’s first quarter saw a substantial shortfall versus Wall Street expectations, prompting a significant negative market response. Management attributed the revenue and earnings declines primarily to a weaker retail environment early in the quarter and disruption caused by the full product line reset. CEO Linda Findley highlighted that demand improved in March as new products were introduced and legacy inventory was cleared, but most of the sales benefit will not materialize until subse
StockJumpers analysis and trade plans are uploaded generally 1 HOUR BEFORE MARKETS CLOSE (3PM EST) for most events.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is stripped down to only what is needed to make the best possible decision(s) on trading the trajectory.
Members who are too busy to manual trade can use Trade Assist. For more information visit here
Avg Daily Volume: 622,224 Market Cap: 1.29B
Sector: None Short Interest: 23.5
Ticker delayed 20 minutes
NOTICE: All material on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.